Evidence map›Paper›PMID 28324534›Full record

Review3 Biotech2015

Toll-like receptor-associated keratitis and strategies for its management.

Amandeep Kaur, Vijay Kumar, Simranjeet Singh, Joginder Singh, Niraj Upadhyay, Shivika Datta, Sourav Singla, Virender Kumar

Open access · hybridAbstract readReview
In one paragraph

Review in 3 Biotech, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Role of SREC-Ⅰ in Innate Immunity to Aspergillus fumigatus Keratitis.Investigative ophthalmology & visual science · 2021
    Article
  5. Article
  6. Frontiers in immunology · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Amandeep KaurDepartment of Biotechnology, Lovely Professional University, Phagwara, 144411, Punjab, India.
Vijay KumarDepartment of Chemistry, Lovely Professional University, Phagwara, 144411, Punjab, India.
Simranjeet SinghDepartment of Biotechnology, Lovely Professional University, Phagwara, 144411, Punjab, India.
Joginder SinghDepartment of Chemistry, Lovely Professional University, Phagwara, 144411, Punjab, India.
Niraj UpadhyayDepartment of Chemistry, Lovely Professional University, Phagwara, 144411, Punjab, India. nivij.res@gmail.com.
Shivika DattaDepartment of Zoology, Lovely Professional University, Phagwara, 144411, Punjab, India.
Sourav SinglaDepartment of Biotechnology, Lovely Professional University, Phagwara, 144411, Punjab, India.
Virender KumarDepartment of Chemistry, Lovely Professional University, Phagwara, 144411, Punjab, India.
Lovely Professional University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratitis is an inflammatory condition, characterized by involvement of corneal tissues. Most recurrent challenge of keratitis is infection. Bacteria, virus, fungus and parasitic organism have potential to cause infection. TLR are an important class of protein which has a major role in innate immune response to combat with pathogens. In last past years, extensive research efforts have provided considerable abundance information regarding the role of TLR in various types of keratitis. This paper focuses to review the recent literature illustrating amoebic, bacterial, fungal and viral keratitis associated with Toll-like receptor molecules and summarize existing thoughts on pathogenesis and treatment besides future probabilities for prevention against TLR-associated keratitis.

Indexed as

CytokinesInfectionKeratitisToll-like receptorTreatment

Identifiers

PMID28324534
PMCPMC4569616
OpenAlexW2070773608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.